Julius M. Wilder

Dr. Julius M. Wilder

Hepatology
234 Crooked Creek Pkwy, 
Durham, NC 
On Staff At
Accepting New Patients
Offers Telehealth
234 Crooked Creek Pkwy, 
Durham, NC 
OverviewInsuranceLocationsClinical Research

Overview

I enjoy meeting my patients, learning their story and helping them feel better. I pride myself on being a good father, husband, friend and physician. My favorite things to do on the weekend include playing with my sons, drinking wine with my wife, grilling out, working in my yard, eating seafood, watching football and going to church.

Dr. Wilder is rated as an Experienced provider by MediFind in the treatment of Porphyria. His top areas of expertise are Hepatitis, Hepatitis C, Jaundice, Liver Transplant, and Endoscopy.

His clinical research consists of co-authoring 43 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hepatology
Licenses
Internal Medicine in NC
Board Certifications
American Board Of Internal Med, Gastroenterology
American Board Of Internal Med, Transplant Hepatology
Fellowships
Gastroenterology, Duke University Medical Center, Transplant Hepatology, Duke University Medical Center
Hospital Affiliations
Duke Regional Hospital
Duke University Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Duke Cardiometabolic Prevention South Durham
234 Crooked Creek Pkwy, Durham, NC 27713

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
Enrollment Status: Active_not_recruiting
Publish Date: November 20, 2025
Intervention Type: Drug
Study Drug: Volixibat
Study Phase: Phase 2
A Multicenter, Open-label Study of Harvoni ® (Sofosbuvir Ledipasvir Fixed Dose Combination) in Subjects Infected With Chronic Hepatitis C and Advanced Heart Failure or Lung Disease
A Multicenter, Open-label Study of Harvoni ® (Sofosbuvir Ledipasvir Fixed Dose Combination) in Subjects Infected With Chronic Hepatitis C and Advanced Heart Failure or Lung Disease
Enrollment Status: Completed
Publish Date: April 21, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

43 Total Publications

Disparities in Alcohol-Related Liver Disease.
Disparities in Alcohol-Related Liver Disease.
Journal: Clinics in liver disease
Published: November 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wilder's expertise for a condition
ConditionClose
    View All 23 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile